Apis Capital Advisors, LLC Fennec Pharmaceuticals Inc. Transaction History

Apis Capital Advisors, LLC

  • $91.4 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
SELL
$7.15 - $8.94 $143,000 - $178,800
-20,000 Reduced 22.22%
70,000 $525,000
Q1 2023

May 12, 2023
BUY
$7.38 - $10.35 $236,160 - $331,200
32,000 Added 55.17%
90,000 $748,000
Q4 2022

Feb 14, 2023
BUY
$7.63 - $10.22 $442,540 - $592,760
58,000 New
58,000 $556,000

Others Institutions Holding FENC

# of Institutions
64
Shares Held
14.7M
Call Options Held
10K
Put Options Held
83.8K
View Full List

About FENNEC PHARMACEUTICALS INC.

FENC Quotes by TradingView
  • Ticker FENC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,067,300
  • Market Cap $165M
  • Description
  • Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...
More about FENC
Track This Portfolio

Track Apis Capital Advisors, LLC Portfolio

Follow Apis Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apis Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apis Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email